Account
Dentsu India wins creative & strategic mandate for Hug Innovations
MUMBAI: Dentsu India has bagged the strategic and creative mandate for the World’s first gesture-controlled Smartwatch Hug.
Dentsu India CEO Simi Sabhaney said, “We look forward to creating some great work for Hug, a brand that is poised to redefine the smartwatch category in India.”
Hug Innovations founder and CEO Raj Neravati, said, “Dentsu’s passion and belief in the Hug smartwatch caught our attention right from the first conversation. Their creative ideas were clear and modern and the category positioning was sharp. We are very excited to partner with Dentsu, and their ability in positioning Hug as a brand as well.”
Commenting on the win, Dentsu India vice president Vidya Sankar said, “This category has tremendous potential to deliver great work both offline and in the digital space. Our understanding of the category, strategic direction and our integrated approach nailed the win.”
Isobar business head Rahul Vengalil added, “We are excited to be working with Hug, world’s first gesture control smartwatch. This is a great opportunity to build a brand ground up using all mediums effectively, with digital being a very important part of the marketing mix.”
MUMBAI: BigTrunk Communications, an integrated digital marketing agency known for driving brand transformations across industries, has been awarded the digital marketing mandate for Soframycin, one of India’s most trusted antiseptic cream brands from the EncubeEthicals portfolio. With this collaboration, Soframycin makes its debut into the digital space, aiming to amplify its presence across India through compelling social media narratives and data-led campaigns. BigTrunk will lead the brand’s digital strategy and execution, with a focus on connecting Soframycin’s legacy of trust with today’s health-conscious and digitally engaged audience.
Soframycin has been a household name for generations, widely recognized for its efficacy in treating cuts, burns, and wounds. Backed by the scientific rigor and pharmaceutical expertise of EncubeEthicals, a pharmaceutical powerhouse since 1998, the brand benefits from the expertise of over 1,400 professionals, including more than 200 R&D specialists and a robust team of quality experts. With a presence in over 50 countries, Encube’s commitment to excellence in topical formulations adds deep credibility to Soframycin’s legacy. Now, as the brand enters the digital space, BigTrunk Communications will lead the charge in reimagining Soframycin’s story—creating modern, relatable digital experiences that stay true to its heritage.
“As we take Soframycin into its next chapter of growth, embracing digital media is not just a strategy but a necessity. We wanted a partner who could translate our scientific credibility into engaging, relatable content for today’s audience,” said Soframycin vice president – marketing, Ajay Rawal. “BigTrunk’s deep understanding of healthcare communications and digital behavior makes them the ideal partner to build meaningful narratives around wound care, trust, and wellbeing.”
“Soframycin is more than a product—it’s a legacy deeply rooted in care and science,” added BigTrunk Communications founder & managing director Bharat Subramaniam. “We’re excited to take on this responsibility of guiding a heritage brand into the digital world. Our focus will be on creating contextual storytelling and purpose-driven campaigns that bring Soframycin closer to Indian families, both old and new.”
